61
1
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8827 |
EMAC10101d
|
Carbonic Anhydrase | Metabolism |
EMAC10101d 是 hCA II 选择性抑制剂(Ki:8.1 nM)。 | |||
T0142 |
Brinzolamide
布林佐胺,AL-4862 |
Carbonic Anhydrase | Metabolism |
Brinzolamide (AL-4862) 是一种碳酸酐酶(carbonic anhydrase)II 抑制剂(IC50:3.19 nM)。 | |||
T61982 | Human carbonic anhydrase II-IN-2 | ||
Human carbonic anhydrase II-IN-24 (Compound R-13) 是一种有效的人碳酸酐酶(hCA)抑制剂。Human carbonic anhydrase II-IN-24抑制 hCA I、II、IV 和 IX 的 Ki 分别为 60.7、320.7 和 2298 和 35.2 nM。 | |||
T6503 |
Fluorometholone Acetate
NSC 47438,Flarex,Eflone,氟米龙醋酸酯,Oxylone acetate |
Glucocorticoid Receptor; Carbonic Anhydrase | Endocrinology/Hormones; Metabolism |
Fluorometholone Acetate (Oxylone acetate) 是合成的糖皮质激素皮质类固醇及皮质类固醇酯。它有效抑制碳酸酐酶 (CA) 对 hCA-I(IC50:2.18 μM)和 hCA-II(IC50:17.5 μM)。它具有抗炎活性,可用于研究外部眼部炎症。 | |||
T61981 | Human carbonic anhydrase II-IN-1 | ||
Human carbonic anhydrase II-IN-1 (Compound S-13) 是一种有效的人碳酸酐酶 II (hCA II) 抑制剂。Human carbonic anhydrase II-IN-1抑制 hCA II,其他 hCA 同工型 I、IV 和 IX 的分别 Ki 为 4.4 nM、 9.2 nM、480.2 nM 和 14.7 nM。Human carbonic anhydrase II-IN-1可用于青光眼的研究。 | |||
T2134 |
Dorzolamide hydrochloride
MK507 hydrochloride,L671152 hydrochloride,MK-507 (L-671152) HCl,盐酸多佐胺,Dorzolamide HCl |
Carbonic Anhydrase | Metabolism |
Dorzolamide hydrochloride (MK507 hydrochloride) 是一种碳酸酐酶carbonic anhydrase II 抑制剂,能够抑制红细胞CA-II(IC50:0.18 nM) 和CA-I(IC50:600 nM) 。 | |||
T63305 |
Carbonic anhydrase inhibitor 6
|
Carbonic Anhydrase | Metabolism |
Carbonic anhydrase inhibitor 6 是一种高效的人碳酸酐酶 (hCA) 抑制剂,抑制 hCA IX,hCA II,hCA XII和hCA I,可用于研究碳酸酐酶异常引起的疾病。 | |||
T67775 |
Enpp/Carbonic anhydrase-IN-1
|
PDE; Carbonic Anhydrase | Metabolism |
Enpp/Carbonic anhydrase-IN-1 (compound 1e) 是有效的 Enpp 和 carbonic anhydrase 抑制剂。Enpp/Carbonic anhydrase-IN-1抑制 NPP1、NPP2、NPP3、CA-II、CA-IX 的 IC50 值分别 1.36、1.35、3.00、0.88、1.02 µM。Enpp/Carbonic anhydrase-IN-1 选择性抑制癌细胞的增殖,对正常细胞毒性较低。 | |||
T67774 |
Compound CDy9
|
Carbonic Anhydrase | Metabolism |
Compound CDy9 是碳酸酐酶(CA)的高选择性抑制剂,对hCA II 的IC50值为0.18μM。 | |||
T80663 |
hCAI/II/IV-IN-28
WAY-638358 |
Carbonic Anhydrase | Metabolism |
hCAI/II/IV-IN-28(WAY-638358) 是一种有效的碳酸酐酶抑制剂,具有潜在抗惊厥活性。 | |||
T61745 |
hCAI/II-IN-6
|
Carbonic Anhydrase | Metabolism |
hCAI/II-IN-6 是一种具有选择性和口服活性的human carbonic anhydrase(CA) 抑制剂。hCAI/II-IN-6对 hCA I,hCA II,hCA VII 和 hCA XII 有抑制作用,Ki 值分别为 220,4.9,6.5 和 >50000 nM。hCAI/II-IN-6 在体内显示抗惊厥活性。hCAI/II-IN-6 可以用于研究癫痫。 | |||
T36758 |
CAIX Inhibitor S4
S4 |
Carbonic Anhydrase | Metabolism |
CAIX Inhibitor S4 (S4) 是一种有效的碳酸酐酶 IX/XII 抑制剂,Ki 分别为 7 nM 和 2 nM。 CA II 和 CA I 的 Ki 分别为 546 和 5600 nM。 | |||
T0106 |
Methazolamide
L584601,醋甲唑胺,CL 8490 |
Carbonic Anhydrase | Metabolism |
Methazolamide (CL 8490) 是一种磺胺衍生物,用作碳酸酐酶 (carbonic anhydrase) 抑制剂,对人 carbonic anhydrase II 的 Ki=为 14 nM。它是降低眼压的药物,能够抑制由青光眼及其他眼病引起的眼压升高的作用。 | |||
T23782 |
Benzolamide
CL-11366,W 1803,CL 11366,CL11366,苯唑拉胺,W-1803 |
Carbonic Anhydrase | Metabolism |
Benzolamide (CL 11366) 是碳酸酐酶 (CA) 抑制剂,抑制hCA I(Ki:15 nM)、hCA II(Ki:9 nM)、EcoCAγ(Ki:94 nM)、VchCAγ(Ki:78 nM)、CAS3(Ki:54 nM)。它可用于研究青光眼和癫痫。 | |||
T73177 |
hCAII-IN-9
|
Carbonic Anhydrase | Metabolism |
hCAII-IN-9 是一种强效的碳酸酐酶抑制剂,对hCA II、hCA IX 和hCA XII 有抑制作用,IC50 分别为 1.18 μM 和 0.17 μM , and 2.99 μM 。hCAII-IN-9 没有血脑屏障透过性。 | |||
T0267 |
Zonisamide
AD 810,唑尼沙胺,CI 912 |
Calcium Channel; Sodium Channel; Carbonic Anhydrase | Membrane transporter/Ion channel; Metabolism |
Zonisamide (AD 810) 是锌酶碳酸酐酶 (carbonic anhydrase) 的有效抑制剂,对人类线粒体同工酶 hCA II 和 hCA V 作用的 Ki 值分别为 35.2 nM 和 20.6 nM。Zonisamide 具有抗癫痫活性,在癫痫、癫痫发作和帕金森病的研究中具有价值。 | |||
T27673 |
JNJ-26990990
|
Others | Others |
JNJ-26990990 是一种广谱抗惊厥药,是上市药物托吡酯的第二代后续药物。它被设计成具有与托吡酯相同的抗惊厥作用,但没有与托吡酯的碳酸酐酶抑制相关的副作用。它还具有治疗炎症性疼痛、神经性疼痛和抑郁症的潜在用途。 | |||
T0782 |
Benzthiazide
Aquatag,苄噻嗪,Lemazide,Dihydrex |
Carbonic Anhydrase | Metabolism |
Benzthiazide (Lemazide) 是长效利尿剂及抗高血压剂。它也是碳酸酐酶 9 的抑制剂,他对 CA9,CA2 和 CA1 的 Ki 分别为 8.0,8.8 和 10 nM。它对肿瘤细胞增殖具有抑制作用。 | |||
T61120 |
Carbonic anhydrase inhibitor 2
|
||
Carbonic Anhydrase Inhibitor2 (compound 7c) 是一种针对 Carbonic Anhydrase II 抑制剂,有效降低青光眼兔眼压。 | |||
T61980 | Carbonic anhydrase inhibitor 8 | ||
Carbonic anhydrase inhibitor 8 (compound R-13) 是一种有效的人碳酸酐酶 (hCA) 抑制剂。Carbonic anhydrase inhibitor 8抑制 hCA I、hCA II、hCA IV 的Ki 值分别为 60.7 nM、320.7 nM、2298 nM。 | |||
T62666 |
Carbonic anhydrase inhibitor 7
|
||
Carbonic anhydrase inhibitor 7 是一种人碳酸酐酶 (hCA) 的有效抑制剂,作用于 hCA IX (Ki: 6.5 nM),hCA II (Ki: 7.1 nM),hCA XII (Ki: 72.1 nM) 和 hCA I (Ki: 255.8 nM)。 | |||
T60848 | Carbonic anhydrase inhibitor 3 | ||
Carbonic anhydrase inhibitor 3 (compound 11g) 可降低青光眼兔的眼压,它是一种碳酸酐酶 II 的抑制剂,。 | |||
T78840 |
Carbonic anhydrase inhibitor 15
|
Carbonic Anhydrase | Metabolism |
Carbonic anhydrase inhibitor15 (Compound 8) 是具有Ki值为8.5 nM对hCA II的碳酸酐酶抑制剂,同时展现出镇痛效应。 | |||
T61292 | CAII-IN-1 | ||
CAII-IN-1 (compound 3n) is a thiosemicarbazide derivative that acts as a potent and selective inhibitor of carbonic anhydrase-II (CA-II), with an IC50 value of 10.3 μM for bovine CA-II. This compound (CAII-IN-1) finds utility in research pertaining to carbonic anhydrase-associated biological disorders [1]. | |||
T62976 | Carbonic anhydrase inhibitor 5 | ||
Carbonic anhydrase inhibitor 5 是一种有效的、选择性的人碳酸酐酶 (hCA) 抑制剂,能够作用于 hCA II (IC50: 42.9 nM)、hCA IX (IC50: 47.6 nM) 和 hCA XII (IC50: 6.7 nM)。 | |||
T61340 | CAII-IN-3 | ||
CAII-IN-3 (compound 3h) is a thiosemicarbazone derivative known for its potent inhibition of carbonic anhydrase-II (CA-II). It exhibits an IC50 value of 13.4 μM [1]. | |||
T63731 | Carbonic anhydrase inhibitor 9 | ||
Carbonic anhydrase inhibitor 9 是碳酸酐酶 (CA) 的有效抑制剂,能够作用于 hCA II (Ki: 56.4 nM) 和 IX (Ki: 56.9 nM),表现出抗增殖效果。 | |||
T63005 |
Carbonic anhydrase inhibitor 11
|
||
Carbonic anhydrase inhibitor 11 (compound VI) 是一种有效的、选择性碳酸酐酶抑制剂,能够作用于 CA II (Ki: 40 nM)、CA IX (Ki: 39 nM) 和 CA XII (Ki: 900 nM)。 | |||
T61842 | Carbonic anhydrase inhibitor 14 | ||
Carbonic anhydrase inhibitor 14 (Compound 8b) is a potent CA inhibitor, exhibiting K i values of 1203, 99.7, 9.4, and 27.7 nM against hCA I, hCA II, hCA IX, and hCA XII, respectively. Additionally, it effectively inhibits CDK2 with an IC 50 of 20.3 μM. Furthermore, Carbonic anhydrase inhibitor 14 demonstrates significant antitumor activity [1]. | |||
T63467 | hCAII-IN-5 | ||
hCAII-IN-5 (compound 12h),一种对人碳酸酐酶 II (hCA II) 具有选择性的有效抑制剂,IC50值为4.55 μM。 | |||
T74587 |
Phenylsulfamide
|
||
Phenylsulfamide (Compound 10) 是一种人碳酸酐酶-II (hCA-II) 抑制剂,Kd 值为 45.50 μM,Ki 值为 79.60 μM。 | |||
T64241 | Brinzolamide hydrochloride | ||
Brinzolamide (AL-4862) hydrochloride 是一种碳酸酐酶 II(carbonic anhydrase II)的选择性抑制剂 (IC50: 3.2 nM)。Brinzolamide hydrochloride 能够抑制睫状体 CA-II,减少房水分泌,进而降低眼压 (IOP)。Brinzolamide hydrochloride 能够用于研究青光眼疾病。 | |||
T83137 |
ALP/Carbonic anhydrase-IN-1
|
Carbonic Anhydrase | Metabolism |
ALP/Carbonic anhydrase-IN-1(Compound 1e)为碳酸酐酶(CA)与碱性磷酸酶(ALP)的双效抑制剂。对CA-II、CA-IX、CA-XII和ALP具有显著抑制活性,其IC50值分别为0.44 µM、1.61 µM、0.51 µM和0.107 µM。 | |||
T63805 |
β-Glucuronidase/hCAII-IN-1
|
||
β-Glucuronidase/hCAII-IN-2 (Compound 12e) 是一种有效的β-glucuronidase 和 hCA II 抑制剂,其 IC50分别为 440.1 μM 和 4.91 μM。 | |||
T61974 | CAII-IN-2 | ||
CAII-IN-2 (compound 3g) 是一种硫代氨基脲衍生物。CAII-IN-2是一种有效的选择性碳酸酐酶-II (CA-II) 抑制剂,抑制牛 CA-II 的 IC50为 12.1 μM。CAII-IN-2 在碳酸酐酶相关生物疾病中具有研究价值。 | |||
T63908 |
hCAII-IN-4
|
||
hCAII-IN-4 (Compound 12j) 是一种有效的hCA II 抑制剂,IC50为 7.78 μM。hCAII-IN-4 也抑制β-glucuronidase,IC50为 773.9 μM。 | |||
T62892 |
hCAI/II-IN-1
|
||
hCAI/II-IN-1 (Compound 3h) 是一种人碳酸酐酶 I 和 II (hCA I/II) 抑制剂,作用于 hCA I (IC50: 0.047 μM) 和 hCA II (IC50: 0.024 μM)。 | |||
T35713 | N-desethyl Brinzolamide (oxalate) | ||
N-desethyl Brinzolamide is an active metabolite of the carbonic anhydrase (CA) inhibitor brinzolamide .1It inhibits CAII and CAIV activities (IC50s = 1.28 and 128 nM, respectively). 1.Kim, C.-Y., Whittington, D.A., Chang, J.S., et al.Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IVJ. Med. Chem.45(4)888-893(2002) | |||
T61282 |
hCAI/II-IN-2
|
||
hCAI/II-IN-2 (compound 2b) is a highly effective dual inhibitor of human carbonic anhydrase I and II (hCA I/II), with Ki values of 40.97 nM, 15.15 nM, and 61.88 nM for hCA I, hCA II, and hCA IX, respectively. With its anti-hypoxic properties, hCAI/II-IN-2 demonstrates activity against acute mountain sickness (AMS). Furthermore, this compound exhibits low cellular activity [1]. | |||
T63557 |
hCA I-IN-1
|
||
hCA I-IN-1 是一种人碳酸酐酶 I (hCA I)抑制剂,能够作用于 hCA I (Ki: 38.3 nM)、hCA II (Ki: 716.4 nM)、hCAIX (Ki: 940.1 nM) 和 hCAXII (Ki: 192.8 nM)。 | |||
T62101 |
hCAXII-IN-2
|
||
hCAXII-IN-2 (compound 5i) 是一种人碳酸酐酶 XII (hCA XII) (Ki: 84.2 nM) 和 hCA IX (Ki: 268.5 nM) 的有效抑制剂,对 hCA I 和 hCA II 具有较低的活性。 | |||
T61164 | hCAII-IN-3 | ||
hCAII-IN-3 (Compound 16) is an inhibitor of human carbonic anhydrase (hCA). It exhibits high affinity for hCA I, hCA II, hCA IX, and hCA XII, with Ki values of 403.8 nM, 5.1 nM, 10.2 nM, and 5.2 nM, respectively. Notably, hCA IX-IN-2 demonstrates anticancer activity [1]. | |||
T63972 |
hCA I-IN-2
|
||
hCA I-IN-2 (Compound 6d) 是人碳酸酐酶 I (hCA I)的选择性抑制剂,能够作用于 hCA I (Ki: 18.8 nM)、hCA II (Ki: 375.1 nM)、hCAIX (Ki: 1721 nM) 和 hCAXII (Ki: 283.9 nM)。 | |||
T63752 | hCAII-IN-1 | ||
hCAII-IN-1 (compound 7f) 是选择性的、有效的碳酸酐酶 (CA II/IX) 抑制剂,他们的 Kis 值分别为 1.2 和 113.6 nM。hCAII-IN-1 对癌症疾病表现出研究潜力。 | |||
T74331 | hCAII-IN-7 | ||
hCAII-IN-7 (Compound R-13) 是一种有效的人碳酸酐酶(hCA)抑制剂,对 hCA I、II、IV 和 IX 的 Ki 分别为 60.7、320.7 和 2298 和 35.2 nM。 | |||
T63631 |
hCAII-IN-2
|
||
hCAII-IN-2 是胞质型人碳酸酐酶 (hCA) 抑制剂,能够作用于 hCA I (Ki: 261.4 nM)、hCA II (Ki: 3.8 nM)、hCA IX (Ki: 19.6 nM)和 hCA XII (Ki: 45.2 nM)。 | |||
T61263 | hCA IX-IN-1 | ||
hCA IX-IN-1 (Compound 6f) 是一种人碳酸酐酶 (hCA) 抑制剂,对 hCA I、hCA II、hCA IX 和 hCA XII 的 Ki 值分别为 331.4、28.4、9.4 和 17.8 nM。 | |||
T63764 | hCA XII/II/IX-IN-1 | ||
hCA XII/II/IX-IN-1 是人碳酸酐酶 (hCA) 的有效抑制剂,能够作用于 hCA I (IC50: 2.6 μM)、 hCA II (IC50: 0.004 μM)、hCA IX (IC50: 0.005 μM) 和 hCA XII (IC50: 0.001 μM)。hCA XII/II/IX-IN-1 表现出抗癌效果。 | |||
T72840 |
hCAIX/XII-IN-6
|
||
hCAIX/XII-IN-6 是具有口服活性的碳酸酐酶(CA)抑制剂,能够抑制人体 CA 亚型 hCA I、II、IV、IX 及 XII,其 Ki 值分别为 6697 nM、2950 nM、4093 nM、4.1 nM 和 7.7 nM。适用于类风湿关节炎(RA)研究。 | |||
T63753 |
hCAIX-IN-3
|
||
hCAII-IN-3 (compound 7e) 是选择性的、有效的碳酸酐酶 (CA II/IX) 抑制剂,他们的 Kis 值分别为 124.2 和 30.5 nM。hCAII-IN-1 对癌症疾病表现出研究潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2095 |
Pomiferin
|
NOS; NF-κB; PDE | Immunology/Inflammation; Metabolism; NF-κB |
Pomiferin is a natural product inhibitor of carbonic anhydrase I and II isoenzymes. It has anticancer, antibacterial and antidiabetic properties. Pomiferin has anti-inflammatory and neuroprotective activities. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01735 |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His)
HEL-S-282,CA-II,HEL-76,CAII,carbonic |
Human | E. coli |
Carbonic Anhydrase 2 Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 30 kDa and the accession number is P00918. | |||
TMPH-03259 |
Carbonic Anhydrase 2 Protein, Rat, Recombinant (His)
CA-II,Carbonate dehydratase II,Carboni... |
Rat | E. coli |
Essential for bone resorption and osteoclast differentiation. Reversible hydration of carbon dioxide. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6. Carbonic Anhydrase 2 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 31.7 kDa and the accession number is P27139. | |||
TMPY-02111 |
Carbonic Anhydrase 2 Protein, Mouse, Recombinant (His)
Car-2,Lvtw-5,Ca2,Ltw-5,carbonic anhydrase ... |
Mouse | E. coli |
Carbonic Anhydrase 2 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 30.4 kDa and the accession number is AAH55291.1. | |||
TMPJ-00701 |
Carbonic Anhydrase 11 Protein, Human, Recombinant (His)
Carbonic Anhydrase-Related Protein 2,CARP ... |
Human | HEK293 Cells |
Carbonic Anhydrase-Related Protein 11 (CA11) is a secreted protein member of the α-carbonic anhydrase family. Carbonic Anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. CA11 is expressed abundantly in the brain with moder... |